International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -899 | -548 | -383 | -599 | -2,724 |
| Depreciation Amortization | 262 | 195 | 130 | 66 | 253 |
| Accounts receivable | -441 | -265 | -144 | -34 | 1,112 |
| Accounts payable and accrued liabilities | 148 | 251 | 109 | 152 | -294 |
| Other Working Capital | -823 | -571 | -447 | -191 | 623 |
| Other Operating Activity | 456 | -43 | -22 | 212 | 689 |
| Operating Cash Flow | $-1,297 | $-981 | $-757 | $-394 | $-341 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -13 | N/A | N/A | -28 |
| Purchase Sale Intangibles | -22 | -14 | -6 | -2 | -80 |
| Other Investing Activity | -22 | -14 | -6 | -2 | -80 |
| Investing Cash Flow | $-45 | $-27 | $-6 | $-2 | $-108 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 824 | 824 | 824 | 824 | 654 |
| Financing Cash Flow | $824 | $824 | $824 | $824 | $654 |
| Beginning Cash Position | 689 | 689 | 689 | 689 | 484 |
| End Cash Position | 171 | 505 | 750 | 1,117 | 689 |
| Net Cash Flow | $-518 | $-184 | $61 | $428 | $205 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,297 | -981 | -757 | -394 | -341 |
| Capital Expenditure | -23 | -13 | N/A | N/A | -28 |
| Free Cash Flow | -1,320 | -994 | -757 | -394 | -369 |